Year |
Citation |
Score |
2019 |
Cress BF, Bhaskar U, Vaidyanathan D, Williams A, Cai C, Liu X, Fu L, M-Chari V, Zhang F, Mousa SA, Dordick JS, Koffas MAG, Linhardt RJ. Heavy heparin: A stable isotope-enriched, chemoenzymatically-synthesized, poly-component drug. Angewandte Chemie (International Ed. in English). PMID 30870573 DOI: 10.1002/Anie.201900768 |
0.764 |
|
2015 |
Bhaskar U, Hickey AM, Li G, Mundra RV, Zhang F, Fu L, Cai C, Ou Z, Dordick JS, Linhardt RJ. A purification process for heparin and precursor polysaccharides using the pH responsive behavior of chitosan. Biotechnology Progress. PMID 26147064 DOI: 10.1002/Btpr.2144 |
0.758 |
|
2015 |
Bhaskar U, Li G, Fu L, Onishi A, Suflita M, Dordick JS, Linhardt RJ. Combinatorial one-pot chemoenzymatic synthesis of heparin. Carbohydrate Polymers. 122: 399-407. PMID 25817684 DOI: 10.1016/J.Carbpol.2014.10.054 |
0.739 |
|
2014 |
Cai C, Dickinson DM, Li L, Masuko S, Suflita M, Schultz V, Nelson SD, Bhaskar U, Liu J, Linhardt RJ. Fluorous-assisted chemoenzymatic synthesis of heparan sulfate oligosaccharides. Organic Letters. 16: 2240-3. PMID 24697306 DOI: 10.1021/Ol500738G |
0.695 |
|
2014 |
Fu L, Zhang F, Li G, Onishi A, Bhaskar U, Sun P, Linhardt RJ. Structure and activity of a new low-molecular-weight heparin produced by enzymatic ultrafiltration. Journal of Pharmaceutical Sciences. 103: 1375-83. PMID 24634007 DOI: 10.1002/Jps.23939 |
0.758 |
|
2013 |
Xiong J, Bhaskar U, Li G, Fu L, Li L, Zhang F, Dordick JS, Linhardt RJ. Immobilized enzymes to convert N-sulfo, N-acetyl heparosan to a critical intermediate in the production of bioengineered heparin. Journal of Biotechnology. 167: 241-7. PMID 23835156 DOI: 10.1016/J.Jbiotec.2013.06.018 |
0.76 |
|
2013 |
Hickey AM, Bhaskar U, Linhardt RJ, Dordick JS. Effect of eliminase gene (elmA) deletion on heparosan production and shedding in Escherichia coli K5. Journal of Biotechnology. 165: 175-7. PMID 23583654 DOI: 10.1016/J.Jbiotec.2013.03.018 |
0.659 |
|
2013 |
Restaino OF, Bhaskar U, Paul P, Li L, De Rosa M, Dordick JS, Linhardt RJ. High cell density cultivation of a recombinant E. coli strain expressing a key enzyme in bioengineered heparin production. Applied Microbiology and Biotechnology. 97: 3893-900. PMID 23318839 DOI: 10.1007/S00253-012-4682-Z |
0.675 |
|
2012 |
Bhaskar U, Sterner E, Hickey AM, Onishi A, Zhang F, Dordick JS, Linhardt RJ. Engineering of routes to heparin and related polysaccharides. Applied Microbiology and Biotechnology. 93: 1-16. PMID 22048616 DOI: 10.1007/S00253-011-3641-4 |
0.713 |
|
2011 |
Wang Z, Li J, Cheong S, Bhaskar U, Akihiro O, Zhang F, Dordick JS, Linhardt RJ. Response surface optimization of the heparosan N-deacetylation in producing bioengineered heparin. Journal of Biotechnology. 156: 188-96. PMID 21925548 DOI: 10.1016/J.Jbiotec.2011.08.013 |
0.656 |
|
2011 |
Higashi K, Ly M, Wang Z, Masuko S, Bhaskar U, Sterner E, Zhang F, Toida T, Dordick JS, Linhardt RJ. Controlled Photochemical Depolymerization of K5 Heparosan, a Bioengineered Heparin Precursor. Carbohydrate Polymers. 86: 1365-1370. PMID 21841848 DOI: 10.1016/J.Carbpol.2011.06.042 |
0.731 |
|
2011 |
Masuko S, Higashi K, Wang Z, Bhaskar U, Hickey AM, Zhang F, Toida T, Dordick JS, Linhardt RJ. Ozonolysis of the double bond of the unsaturated uronate residue in low-molecular-weight heparin and K5 heparosan. Carbohydrate Research. 346: 1962-6. PMID 21742314 DOI: 10.1016/J.Carres.2011.06.004 |
0.775 |
|
Show low-probability matches. |